KAHR Announces Appointment of Jennifer Minai-Azary to its Board of Directors
JERUSALEM, July 11, 2022 /PRNewswire/ — KAHR, a clinical-stage cancer immunotherapy company developing novel bi-functional fusion proteins, today announced the appointment…